Cromos Pharma, where the patients are

Articles Published in 2012

Sutro, Celgene to develop next-gen ADCs and bispecific antibodies

Wednesday, December 19, 2012 09:14 AM

Sutro Biopharma, a San Francisco-based biopharmaceutical company, has formed a collaboration with Celgene, a multinational biopharmaceutical company, to design and develop novel antibody drug conjugates (ADCs) and bispecific antibodies for two undisclosed targets and to manufacture a proprietary Celgene antibody.

More... »

CRF Health eCOA webinar series

Teva signs new $3B syndicated revolving credit facility

Tuesday, December 18, 2012 02:23 PM

Teva Pharmaceutical Industries, a global pharmaceutical company, has entered into a new five-year, $3 billion unsecured revolving credit facility, which replaces its existing $2.5 billion credit facility.

More... »


DIA appoints Lyngvig as new European director

Tuesday, December 18, 2012 01:55 PM

DIA, a neutral, global, professional and member-driven association of nearly 18,000 professionals, has appointed Jytte Lyngvig as director for DIA Europe.

More... »

Zuckerman gives $200M to Columbia University, endows Mind Brain Behavior Institute

Tuesday, December 18, 2012 12:29 PM

Mortimer B. Zuckerman has pledged $200 million to endow a Mind Brain Behavior Institute at Columbia University to support interdisciplinary neuroscience research and discovery by scholars across the university.

More... »

FDA clears IND for first study protocol developed using crowdsourcing

Tuesday, December 18, 2012 12:02 PM

The FDA has cleared the Investigational New Drug Application (IND) for lisinopril to be assessed as an adjunctive therapy for multiple sclerosis (MS), according to Transparency Life Sciences (TLS), a drug development company based on open innovation.

More... »

ZeinCRO expands to 14 CSEE countries total

Tuesday, December 18, 2012 11:35 AM

ZeinCRO, a CRO based in Europe, has reinforced its position in Central- and South- Eastern Europe (CSEE), with the opening of offices in 5 additional countries, extending its reach to 14 countries in total.

More... »

UAB to enroll patients in pilot study using Mytrus’ iPad app

Tuesday, December 18, 2012 11:08 AM

The University of Alabama at Birmingham (UAB) will use an iPad application developed by Mytrus, a clinical technology and services company for medical and pharmaceutical research, in an upcoming pilot study supported by the U.S. Department of Health & Human Services Agency for Healthcare Research and Quality.  

More... »

IMI launches $319M 8th call for proposals

Tuesday, December 18, 2012 10:41 AM

The Innovative Medicines Initiative (IMI), the world’s largest public-private partnership in health, is launching its eighth call for proposals. With a total budget of $319 million ($188 million cash from IMI, plus a $131 million in-kind contribution from participating EFPIA companies), the projects resulting from this call will tackle some of the biggest challenges in health research.

More... »

Takeda sells non-Colcrys URL Pharma to Sun Pharmaceutical

Tuesday, December 18, 2012 10:13 AM

Takeda Pharmaceuticals U.S.A. has entered into a definitive agreement to sell the non-Colcrys (colchicine, USP) URL Pharma generic business to Caraco Pharmaceutical Laboratories, a wholly-owned subsidiary of Sun Pharmaceutical Industries.

More... »

Soligenix acquires novel innate defense regulator clinical program

Tuesday, December 18, 2012 09:44 AM

Soligenix, a Princeton, N.J.-based development stage biopharmaceutical company, has acquired a novel drug technology, known as SGX94, representing a unique approach to modulation of the innate immune system. 

More... »

`
CenterWatch Data Library
CLINICAL TRIAL RESOURCES

Search:

NEWS ONLINE ARCHIVE

Browse by:

CWWeekly

April 14

Proposal calls for back-to-back trials to measure efficacy and effectiveness prior to FDA approval

Study: Minority populations under-represented in cancer trials, but have higher rates of incidence

Already a subscriber?
Log in to your digital subscription.

Subscribe to CWWeekly.

The CenterWatch Monthly

April

Make way for mobile health in clinical trials
Despite patient retention, data quality benefits, regulatory hurdles persist

Global clinical trial laboratories decentralize
Regional labs reducing complexity, delivering cost and time savings

Already a subscriber?
Log in to your digital subscription.

Purchase the April issue.

Subscribe to
The CenterWatch Monthly.

The CenterWatch Monthly

March

Strategic alliances hit bumps in the road
Mixed relationship performance driving new approaches

Tapping community hospitals for clinical trial volunteers
New study finds high potential but infrastructure, resources are lacking

Already a subscriber?
Log in to your digital subscription.

Purchase the March issue.

Subscribe to
The CenterWatch Monthly.

JobWatch centerwatch.com/jobwatch

Featured Jobs